Ali Salahpour

1 King's College Circle
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Neurodevelopmental disorder-causing GRIN1 Y647S variant alters red blood cell physiology in mice.

Neurodevelopmental disorder-causing GRIN1 Y647S variant alters red blood cell physiology in mice.

Journal: Physiological reports

Published: September 23, 2025

Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome.

Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome.

Journal: EMBO molecular medicine

Published: April 03, 2025

Grin1 Y 647 S/+ Mice: A Preclinical Model of GRIN1 -Related Neurodevelopmental Disorder.

Grin1 Y 647 S/+ Mice: A Preclinical Model of GRIN1 -Related Neurodevelopmental Disorder.

Journal: bioRxiv : the preprint server for biology

Published: September 04, 2024

Combination of Haloperidol With UNC9994, β-arrestin-Biased Analog of Aripiprazole, Ameliorates Schizophrenia-Related Phenotypes Induced by NMDAR Deficit in Mice.

Combination of Haloperidol With UNC9994, β-arrestin-Biased Analog of Aripiprazole, Ameliorates Schizophrenia-Related Phenotypes Induced by NMDAR Deficit in Mice.

Journal: The international journal of neuropsychopharmacology

Published: April 25, 2024

Exploiting spatiotemporal regulation of FZD5 during neural patterning for efficient ventral midbrain specification.

Exploiting spatiotemporal regulation of FZD5 during neural patterning for efficient ventral midbrain specification.

Journal: Development (Cambridge, England)

Published: November 14, 2023

Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.

Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction.

Journal: Nature

Published: November 09, 2023

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Journal: bioRxiv : the preprint server for biology

Published: October 24, 2023

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: October 09, 2023

Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis.

Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis.

Journal: Cannabis and cannabinoid research

Published: October 17, 2022

Evaluation and Validation of Commercially Available Dopamine Transporter Antibodies.

Evaluation and Validation of Commercially Available Dopamine Transporter Antibodies.

Journal: eNeuro

Published: August 24, 2022

Abnormal sensory perception masks behavioral performance of Grin1 knockdown mice.

Abnormal sensory perception masks behavioral performance of Grin1 knockdown mice.

Journal: Genes, brain, and behavior

Published: February 16, 2022

Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.

Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.

Journal: Frontiers in cellular neuroscience

Published: December 10, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026